AF development and atrial remodeling can be successfully prevented by treatment with an antioxidant probucol, which in addition to attenuated oxidative stress, also inhibits NF-κB and proinflammatory and profibrotic cytokines release [63]. Here, NFKB1 is linked to atrial fibrillation.